Owens, E., Hotchkiss, K., Brown, M., Threatt, S., Low, J., Anand, M., … Khasraw, M. (2026). Oncolytic HSV-1 Encoding IL-12 and Anti-PD-1 Reprograms CNS Immunity: Open-Label Study of MVR-C5252 for Safety, Tolerability, and Efficacy (PuMP) 2259418. In The Journal of Immunology (Vol. 215). Oxford University Press (OUP). https://doi.org/10.1093/jimmun/vkag141.710

Owens, Elizabeth, Kelly Hotchkiss, Michael Brown, Stevie Threatt, Justin Low, Monika Anand, Melody Goldston, et al. “Oncolytic HSV-1 Encoding IL-12 and Anti-PD-1 Reprograms CNS Immunity: Open-Label Study of MVR-C5252 for Safety, Tolerability, and Efficacy (PuMP) 2259418.” In The Journal of Immunology, Vol. 215. Oxford University Press (OUP), 2026. https://doi.org/10.1093/jimmun/vkag141.710.

Owens E, Hotchkiss K, Brown M, Threatt S, Low J, Anand M, et al. Oncolytic HSV-1 Encoding IL-12 and Anti-PD-1 Reprograms CNS Immunity: Open-Label Study of MVR-C5252 for Safety, Tolerability, and Efficacy (PuMP) 2259418. In: The Journal of Immunology. Oxford University Press (OUP); 2026.

Owens, Elizabeth, et al. “Oncolytic HSV-1 Encoding IL-12 and Anti-PD-1 Reprograms CNS Immunity: Open-Label Study of MVR-C5252 for Safety, Tolerability, and Efficacy (PuMP) 2259418.” The Journal of Immunology, vol. 215, no. Supplement_1, Oxford University Press (OUP), 2026. Crossref, doi:10.1093/jimmun/vkag141.710.

Owens E, Hotchkiss K, Brown M, Threatt S, Low J, Anand M, Goldston M, Johnson M, Bradbury C, Herndon J, Grant G, Ashley D, Patel A, Desjardins A, Khasraw M. Oncolytic HSV-1 Encoding IL-12 and Anti-PD-1 Reprograms CNS Immunity: Open-Label Study of MVR-C5252 for Safety, Tolerability, and Efficacy (PuMP) 2259418. The Journal of Immunology. Oxford University Press (OUP); 2026.